Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to -$9.4 million.

  • Organogenesis Holdings' Net Cash Flow fell 31045.18% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year decrease of 68363.68%. This contributed to the annual value of $31.8 million for FY2024, which is 293559.16% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Net Cash Flow of -$9.4 million as of Q3 2025, which was down 31045.18% from -$36.8 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Net Cash Flow peaked at $41.2 million during Q4 2024, and registered a low of -$36.8 million during Q2 2025.
  • Moreover, its 5-year median value for Net Cash Flow was $93000.0 (2023), whereas its average is -$1.1 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Net Cash Flow surged by 111612.9% in 2024, and later crashed by 335366.93% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Net Cash Flow (Quarter) stood at $11.8 million in 2021, then crashed by 140.08% to -$4.7 million in 2022, then soared by 216.53% to $5.5 million in 2023, then surged by 647.78% to $41.2 million in 2024, then crashed by 122.71% to -$9.4 million in 2025.
  • Its Net Cash Flow stands at -$9.4 million for Q3 2025, versus -$36.8 million for Q2 2025 and -$25.6 million for Q1 2025.